Clinical Trials List
2022-05-02 - 2027-03-22
Phase III
Not yet recruiting5
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Ya-Ping Chen 無
- 顏志傑 無
- Chun-Hui Lee 無
- Ya-Ting Hsu 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Yao-Chung Liu 未分科
- 蔡淳光 未分科
- Sheng-Hsuan Chien 未分科
- Ting-An Lin 無
- Liang-Tsai Hsiao 未分科
- Po-Shen Ko 未分科
- 陳玟均 未分科
- Hao-Yuan Wang 未分科
- Jyh-Pyng Gau 未分科
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Ching-Chan Lin 無
- Tzu-Ting Chen 無
- Ming-Hung Tsai 未分科
- 鄭富銘 未分科
- Che-Hung Lin 未分科
- Ming-Yu Lien 未分科
- 王秀慈 未分科
- Chen-Yuan Lin 未分科
- Chi-Ching Chen 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Sheng-chieh Chou 無
- MING YAO 無
- 林耘曲 無
- 柯紀綸 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
50 participants
-
Global
914 participants
